Alison C. MacKinnon

8.0k total citations · 2 hit papers
98 papers, 5.8k citations indexed

About

Alison C. MacKinnon is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Alison C. MacKinnon has authored 98 papers receiving a total of 5.8k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Molecular Biology, 40 papers in Immunology and 23 papers in Oncology. Recurrent topics in Alison C. MacKinnon's work include Galectins and Cancer Biology (36 papers), Receptor Mechanisms and Signaling (19 papers) and Peptidase Inhibition and Analysis (16 papers). Alison C. MacKinnon is often cited by papers focused on Galectins and Cancer Biology (36 papers), Receptor Mechanisms and Signaling (19 papers) and Peptidase Inhibition and Analysis (16 papers). Alison C. MacKinnon collaborates with scholars based in United Kingdom, Sweden and United States. Alison C. MacKinnon's co-authors include Tariq Sethi, Christopher Haslett, Neil C. Henderson, Sarah L. Farnworth, John P. Iredale, Stuart J. Forbes, Christine M. Brown, Robert C. Rintoul, Michael Spedding and T Sethi and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Medicine.

In The Last Decade

Alison C. MacKinnon

97 papers receiving 5.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Extracellular matrix proteins protect small cell lung cancer cells against apoptosis: A mechanism for small cell lung cancer growth and drug resistance in vivo

1999 620 citations Tariq Sethi, Robert C. Rintoul et al. profile →
Hepatic progenitor cells of biliary origin with liver repopulation capacity

2015 345 citations Wei‐Yu Lu, Thomas G. Bird et al. Nature Cell Biology profile →

Peers

Countries citing papers authored by Alison C. MacKinnon

Since Specialization

Citations

This map shows the geographic impact of Alison C. MacKinnon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alison C. MacKinnon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alison C. MacKinnon more than expected).

Fields of papers citing papers by Alison C. MacKinnon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alison C. MacKinnon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alison C. MacKinnon. The network helps show where Alison C. MacKinnon may publish in the future.

Co-authorship network of co-authors of Alison C. MacKinnon

This figure shows the co-authorship network connecting the top 25 collaborators of Alison C. MacKinnon. A scholar is included among the top collaborators of Alison C. MacKinnon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alison C. MacKinnon. Alison C. MacKinnon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Effect of GB1107, a novel galectin-3 inhibitor on pro-fibrotic signalling in the liver 2024 ·European Journal of Pharmacology ·Alison C. MacKinnon, Duncan C. Humphries, (unknown), James A. Roper, Ian Holyer, (unknown), Ross Mills, Ulf J. Nilsson, Hakon Leffler, Anders N. Pedersen, Hans Schambye, Fredrik R. Zetterberg, Robert J. Slack	4
2	Abstract LB104: Preclinical evaluation of the role of Galectin-1 in tumor immune evasion associated mechanisms using a highly selective Galectin-1 small molecule inhibitor 2023 ·Cancer Research ·Ian Holyer, R Slack, (unknown), Fredrik R. Zetterberg, Alison C. MacKinnon	1
3	1460P GALLANT-1: GB1211 galectin-3 (Gal-3) inhibitor plus atezolizumab (atz) for first line treatment in patients (pts) with advanced/metastatic non-small cell lung cancer (NSCLC) 2023 ·Annals of Oncology ·Francisco Aparisi, Enriqueta Felip, Éric Pichon, Enric Carcereny, (unknown), (unknown), T Sethi, Bertil Lindmark, Robert J. Slack, Alison C. MacKinnon, Vassilios Aslanis, D. Phung, (unknown), (unknown), Gayle Ross, Linda Basse, (unknown)	1
4	Alternatively activated macrophages promote resolution of necrosis following acute liver injury 2020 ·Journal of Hepatology ·Philip Starkey Lewis, Lara Campana, Niya Aleksieva, Jennifer A. Cartwright, Alison C. MacKinnon, Eoghan O’Duibhir, Timothy J. Kendall, Matthieu Vermeren, Adrian Thomson, Victoria L. Gadd, Benjamin J. Dwyer, Rhona Aird, (unknown), Adriano G. Rossi, Lesley M. Forrester, B. Kevin Park, Stuart J. Forbes	126
5	Galactic-1: A Randomized, Double-Blind, Multicentre, Parallel, Placebo-Controlled Phase 2b Study in Subjects with Idiopathic Pulmonary Fibrosis (IPF) Investigating the Efficacy and Safety of TD139, an Inhaled Galectin-3 Inhibitor Administered via a Dry Powder Inhaler Over 52 Weeks 2020 ·Alison C. MacKinnon, Sanjeev Khindri, Nik Hirani, Hakon Leffler, (unknown), Tavpritesh Sethi, A. Pedersen, Hans Schambye, C McClinton, Robert J. Slack, Toby M. Maher	5
6	An Orally Active Galectin-3 Antagonist Inhibits Lung Adenocarcinoma Growth and Augments Response to PD-L1 Blockade 2019 ·Cancer Research ·Lynda Vuong, (unknown), Claire Rooney, Brian J. McHugh, Sarah Howie, Christopher D. Gregory, Stuart J. Forbes, Neil C. Henderson, Fredrik R. Zetterberg, Ulf J. Nilsson, Hakon Leffler, Paul Ford, Anders N. Pedersen, Lise Gravelle, Susan Tantawi, Hans Schambye, Tariq Sethi, Alison C. MacKinnon	104
7	Galectin‐3‐Binding Glycomimetics that Strongly Reduce Bleomycin‐Induced Lung Fibrosis and Modulate Intracellular Glycan Recognition 2016 ·ChemBioChem ·Tamara Delaine, P.M. Collins, Alison C. MacKinnon, Gunjan Sharma, John Stegmayr, Vishal Kumar Rajput, Santanu Mandal, Ian Cumpstey, (unknown), Bader A. Salameh, Barbro Kahl‐Knutsson, Hilde van Hattum, Monique van Scherpenzeel, Roland J. Pieters, Tariq Sethi, Hans Schambye, Stina Oredsson, Hakon Leffler, Helen Blanchard, Ulf J. Nilsson	151
8	Hepatic progenitor cells of biliary origin with liver repopulation capacity breakdown → 2015 ·Nature Cell Biology ·Wei‐Yu Lu, Thomas G. Bird, Luke Boulter, Atsunori Tsuchiya, Alicia M. Cole, Trevor Hay, Rachel V. Guest, Davina Wojtacha, Tak Yung Man, Alison C. MacKinnon, Rachel A. Ridgway, Timothy J. Kendall, Michael J. Williams, Thomas Jamieson, Alexander Raven, David C. Hay, John P. Iredale, Alan R. Clarke, Owen J. Sansom, Stuart J. Forbes	345
9	CD133+ Cancer Stem-like Cells in Small Cell Lung Cancer Are Highly Tumorigenic and Chemoresistant but Sensitive to a Novel Neuropeptide Antagonist 2014 ·Cancer Research ·(unknown), Alison C. MacKinnon, Nicolaos Avlonitis, Mark Bradley, Robert C. Rintoul, Doris M. Rassl, Wei Wang, Stuart J. Forbes, Christopher D. Gregory, Tariq Sethi	165
10	Bone marrow contributions to fibrosis 2013 ·Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease ·Alison C. MacKinnon, Stuart J. Forbes	14
11	Monocytes Control Second-Phase Neutrophil Emigration in Established Lipopolysaccharide-induced Murine Lung Injury 2012 ·American Journal of Respiratory and Critical Care Medicine ·Kevin Dhaliwal, Emma Scholefield, David A. Ferenbach, Michael Gibbons, Rodger Duffin, David A. Dorward, Andrew Conway Morris, Duncan C. Humphries, Alison C. MacKinnon, Thomas S. Wilkinson, William Wallace, Nico van Rooijen, Matthias Mack, Adriano G. Rossi, Donald J. Davidson, Nik Hirani, Jeremy Hughes, Chris Haslett, A. John Simpson	86
12	Ly6Chi Monocytes Direct Alternatively Activated Profibrotic Macrophage Regulation of Lung Fibrosis 2011 ·American Journal of Respiratory and Critical Care Medicine ·Michael Gibbons, Alison C. MacKinnon, Prakash Ramachandran, Kevin Dhaliwal, Rodger Duffin, Alexander Phythian‐Adams, Nico van Rooijen, Christopher Haslett, Sarah Howie, A. John Simpson, Nikhil Hirani, Jack Gauldie, John P. Iredale, Tariq Sethi, Stuart J. Forbes	363
13	Regulation of Transforming Growth Factor-β1–driven Lung Fibrosis by Galectin-3 2011 ·American Journal of Respiratory and Critical Care Medicine ·Alison C. MacKinnon, Michael Gibbons, Sarah L. Farnworth, Hakon Leffler, Ulf J. Nilsson, Tamara Delaine, A. John Simpson, Stuart J. Forbes, Nik Hirani, Jack Gauldie, Tariq Sethi	397
14	The molecular and cellular biology of lung cancer: identifying novel therapeutic strategies 2010 ·British Medical Bulletin ·Alison C. MacKinnon, Jens Kopatz, T Sethi	35
15	GALECTIN-3 REGULATES EPITHELIAL TO MESENCHYMAL TRANSITION IN LUNG EPITHELIAL CELLS 2008 ·Thorax ·Alison C. MacKinnon, Sarah L. Farnworth, Michael Gibbons, Stuart J. Forbes, T Sethi	1
16	Galectin-3 regulates myofibroblast activation and hepatic fibrosis 2006 ·Proceedings of the National Academy of Sciences ·Neil C. Henderson, Alison C. MacKinnon, Sarah L. Farnworth, Françoise Poirier, Francesco Paolo Russo, John P. Iredale, Christopher Haslett, Kenneth J. Simpson, Tariq Sethi	492
17	Sphingosine Kinase: A Point of Convergence in the Action of Diverse Neutrophil Priming Agents 2002 ·The Journal of Immunology ·Alison C. MacKinnon, (unknown), Edwin R. Chilvers, Adriano G. Rossi, Christopher Haslett, Tariq Sethi	61
18	The Relationship between the Adrenoceptor and Nonadrenoceptor‐Mediated Effects of Imidazoline‐ and Imidazole‐Containing Compounds^fn1 1995 ·Annals of the New York Academy of Sciences ·J.C. McGrath, Christine M. Brown, C.J. Daly, Dave Kendal, Alison C. MacKinnon, D.J. Miller, (unknown), A. O'Dowd, John J. O'Dowd, Darawan Pinthong, Gulzar Singh, A.G.B. Templeton, V.G. Wilson	6
19	[³H]‐lifarizine, a high affinity probe for inactivated sodium channels 1995 ·British Journal of Pharmacology ·Alison C. MacKinnon, Katrina Wyatt, Joseph G. McGivern, (unknown), C. M. Brown	16
20	Affinity of 2-(tetrahydroisoquinolin-2-ylmethyl)- and 2-(isoindolin-2-ylmethyl)imidazolines for .alpha.-adrenoceptors. Differential affinity of imidazolines for the [3H]idazoxan-labeled .alpha.2-adrenoceptor vs the [3H]yohimbine-labeled site 1990 ·Journal of Medicinal Chemistry ·Robin D. Clark, Jacob Berger, Pushkal Garg, Klaus K. Weinhardt, Michael Spedding, A.T. Kilpatrick, Christine M. Brown, Alison C. MacKinnon	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact